Aducanumab (Pending FDA Approval)
Classes: Monoclonal Antibodies, Anti-amyloid Beta
What is Aducanumab?
Aducanumab is under study as a possible treatment of early Alzheimer’s disease and currently pending FDA approval.
Uses of Aducanumab
- possible treatment of early Alzheimer’s disease.
Side effects
Consult your doctor immediately if any side effects occur, worsen, persist or any serious side effects occur.
Precautions
Consult your Physician.
Reviews
There are no reviews yet.